Search

everythinglearnresearchcommunity

for

Search:↓

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

Medications for PCOS don't seem to raise heart disease risk.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Ayurvedic treatment can effectively manage PCOS and its symptoms.

Women with PCOS have more emotional and body image issues than healthy women.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Centratherum anthelminticum seed extract effectively treats Polycystic Ovary Syndrome in rats.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.